Pharmaceutical Care for Smoking Cessation: A Pilot Study on Understanding Knowledge and Experience Through a Mixed-Methods Approach
DOI:
https://doi.org/10.25026/jsk.v6i6.2249Keywords:
experience, knowledge, pharmacist, smoking scessationAbstract
Smoking is one of the biggest threats to public health in the world, so pharmacists should have a role in a multidisciplinary team to provide pharmaceutical care in smoking cessation in pharmacy. The research purpose was to determine the level of knowledge and experience of pharmacist pharmacy services on smoking cessation programs at pharmacists in East Surabaya. This research was mixed-method research, using the explanatory sequential design strategy. Data collection was carried out from October 2021 to January 2022 in Surabaya, East Java, Indonesia. The research variable were knowledge and experience related to pharmaceutical care in smoking cessation. The sample were pharmacists who carried out clinical pharmacy services at pharmacies in East Surabaya. Respondents were interviewed in depth until the data reached the saturation level (saturation so that no new answers/explanations are found) in order to obtain good and usable qualitative data. This study involved 40 respondents. Most of the respondents had sufficient knowledge level (57.50%). Many participants attended seminars on smoking cessation (55%), but none of the respondents had experience in pharmaceutical services. Some respondents have experience in giving advice on smoking cessation to patients during drug delivery at pharmacies (62.50%). Most of the respondents knew dangers of smoking and its relation to health, but most of them cannot explain the theoretical mechanism of the disease pathophysiologically. Pharmacists in pharmacies had sufficient knowledge about smoking cessation, but the practice of pharmaceutical services was still lacking. This could be due to the need to improve information regarding smoking cessation regulations for health workers.
Keywords: experience, knowledge, pharmacist, smoking scessation
References
[1] Lorensia A, Pratama AM, Hersandio R. Knowledge and attitudes on smoking cessation of e-cigarettes: a mixed-methods study of pharmacy students in Surabaya, Indonesia. J Prev Med Hyg. 2022;62(4):E918-E925. doi:10.15167/2421-4248/jpmh2021.62.4.2330.
[2] Holipah H, Sulistomo HW, Maharani A. Tobacco smoking and risk of all-cause mortality in Indonesia. PLoS One. 2020;15(12):e0242558. doi:10.1371/journal.pone.0242558.
[3] Government Regulation of the Republic of Indonesia. Safeguarding Materials Containing Addictive Substances in the Form of Tobacco Products for Health; 2012. [cited 2021 Augst 20]. Available from: https://peraturan.bpk.go.id/Home/Details/5324/pp-no-109-tahun-2012.
[4] Government Regulation of the Republic of Indonesia. Cigarette Security for Health; 2003. [cited 2021 Augst 20].
[5] Jha P. The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries. Elife. 2020;9:e49979. doi:10.7554/eLife.49979.
[6] Patel AR, Patel AR, Singh S, Singh S, Khawaja I. Global Initiative for Chronic Obstructive Lung Disease: The Changes Made. Cureus. 2019;11(6):e4985. doi:10.7759/cureus.4985.
[7] Datta SK, Dennis PA, Davis JM. Health benefits and economic advantages associated with increased utilization of a smoking cessation program. J Comp Eff Res. 2020;9(11):817–28. doi: 10.2217/cer-2020-0005.
[8] Lorensia A, Yudiarso A, Pratama AM. Interpretative Phenomenological Analysis: Pharmacy Student Perceptions of Cigarette Smoking of Health Awareness in Smoking Cessation. Jurnal ANIMA Indonesian Psychological Journal. 2016;31(4):170–9.
[9] Lorensia A, Pratama AM, Hersandio R. Knowledge and Attitudes on Smoking Cessation of e-cigarettes: A Mixed-Methods Study of Pharmacy Students in Surabaya, Indonesia. J Prev Med Hyg. 2021;62(4):E918–25. https://doi.org/10.15167/2421-4248/jpmh2021.62.4.2330.
[10] Chinwong S, Chinwong D. A National Survey of Community Pharmacists on Smoking Cessation Services in Thailand. Pharmacy (Basel). 2018;6(3):101. doi:10.3390/pharmacy6030101.
[11] Lertsinudom S, Kaewketthong P, Chankaew T, Chinwong D, Chinwong S. Smoking Cessation Services by Community Pharmacists: Real-World Practice in Thailand. Int J Environ Res Public Health. 2021;18(22):11890. doi:10.3390/ijerph182211890.
[12] Carson-Chahhoud KV, Livingstone-Banks J, Sharrad KJ, Kopsaftis Z, Brinn MP, To-A-Nan R, Bond CM. Community pharmacy personnel interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2019;10:CD003698. doi: 10.1002/14651858.CD003698.pub3.
[13] Athiyah U, Setiawan CD, Nugraheni G, Zairina E, Utami W, Hermansyah A. Assessment of pharmacists' knowledge, attitude and practice in chain community pharmacies towards their current function and performance in Indonesia. Pharm Pract (Granada). 2019;17(3):1518. doi:10.18549/PharmPract.2019.3.1518
[14] Medhat M, Sabry N, Ashoush N. Knowledge, attitude and practice of community pharmacists towards nutrition counseling. Int J Clin Pharm. 2020;42(6):1456–68. doi: 10.1007/s11096-020-01106-0.
[15] Inoue-Choi M, McNeel TS, Hartge P, Caporaso NE, Graubard BI, Freedman ND. Non-Daily Cigarette Smokers: Mortality Risks in the U.S. Am J Prev Med. 2019;56(1):27–37. doi:10.1016/j.amepre.2018.06.025.
[16] Baumeister RF. Addiction, cigarette smoking, and voluntary control of action: Do cigarette smokers lose their free will?. Addict Behav Rep. 2017;5:67-84. doi:10.1016/j.abrep.2017.01.003.
[17] Wang M, Wang JW, Cao SS, Wang HQ, Hu RY. Cigarette Smoking and Electronic Cigarettes Use: A Meta-Analysis. Int J Environ Res Public Health. 2016;13(1):120. doi:10.3390/ijerph13010120.
[18] Parekh TM, Wu C, McClure LA, Howard VJ, Cushman M, Malek AM, Harrington KF, Cherrington AL, Dransfield MT, Bhatia S. Determinants of cigarette smoking status in a national cohort of black and white adult ever smokers in the USA: a cross-sectional analysis of the REGARDS study. BMJ Open. 2019;9(5):e027175. doi:10.1136/bmjopen-2018-027175.
[19] Sugavanesh P, Pushpanjali K. Nicotine Dependence, Its Risk Indicators, and Exhaled Carbon Monoxide Levels among the Smokers in Bengaluru, India. Indian J Community Med. 2018;43(3):220–3. doi:10.4103/ijcm.IJCM_98_18.
[20] Nguyen AB, Zhao X, Hoffman L, Morse AL, Delahanty J. Nicotine and addiction beliefs and perceptions among the US-born and foreign-born populations. Prev Med. 2018;114:107–14. doi:10.1016/j.ypmed.2018.06.018.
[21] Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, Gong H, Hui C, Xu G, Li Y, Pan L, Zhang B, Shan G. The association between smoking and blood pressure in men: a cross-sectional study. BMC Public Health. 2017;17(1):797. doi:10.1186/s12889-017-4802-x.
[22] Walekhwa SN, Kisa A. Tobacco Use and Risk Factors for Hypertensive Individuals in Kenya. Healthcare (Basel). 2021;9(5):591. doi:10.3390/healthcare9050591.
[23] Langel SN, Kelly FL, Brass DM, Nagler AE, Carmack D, Tu JJ, Travieso T, Goswami R, Permar SR, Blasi M, Palmer SM. E-cigarette and food flavoring diacetyl alters airway cell morphology, inflammatory and antiviral response, and susceptibility to SARS-CoV-2. Cell Death Discov. 2022;8(1):64. doi:10.1038/s41420-022-00855-3.
[24] Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: A narrative review. Tob Induc Dis. 2020;18:60. doi:10.18332/tid/123845.
[25] Dessì A, Corona L, Pintus R, Fanos V. Exposure to tobacco smoke and low birth weight: from epidemiology to metabolomics. Expert Rev Proteomics. 2018;15(8):647–56. doi: 10.1080/14789450.2018.1505508.
[26] Bodin F, McIntyre KM, Schwartz JE, McKinley PS, Cardetti C, Shapiro PA, Gorenstein E, Sloan RP. The Association of Cigarette Smoking With High-Frequency Heart Rate Variability: An Ecological Momentary Assessment Study. Psychosom Med. 2017;79(9):1045–50. doi:10.1097/PSY.0000000000000507.
[27] Wadgave U, Nagesh L. Nicotine Replacement Therapy: An Overview. Int J Health Sci (Qassim). 2016;10(3):425–35.
[28] Devi RE, Barman D, Sinha S, Hazarika SJ, Das S. Nicotine replacement therapy: A friend or foe. J Family Med Prim Care. 2020;9(6):2615–20. doi:10.4103/jfmpc.jfmpc_313_20.
[29] Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5
[30] Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter M. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. JAMA Pediatr. 2019;173(12):1146–53. doi:10.1001/jamapediatrics.2019.3553.
[31] Tonstad S, Arons C, Rollema H, Berlin I, Hajek P, Fagerström K, Els C, McRae T, Russ C. Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations. Curr Med Res Opin. 2020;36(5):713–30. doi: 10.1080/03007995.2020.1729708.
[32] Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol. 2016;6(2):99–144. doi:10.1177/2045125316629071.
[33] Schlam TR, Cook JW, Baker TB, Hayes-Birchler T, Bolt DM, Smith SS, Fiore MC, Piper ME. Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?. Psychopharmacology (Berl). 2018;235(7):2065–75. doi:10.1007/s00213-018-4903-y.
[34] Ayuningtyas DA, Tuinman MA, Prabandari YS, Hagedoorn M. Smoking Cessation Experience in Indonesia: Does the Non-smoking Wife Play a Role?. Front Psychol. 2021;12:618182. doi:10.3389/fpsyg.2021.618182.
[35] Septiono W, Kuipers MAG, Ng N, Kunst AE. The impact of local smoke-free policies on smoking behaviour among adults in Indonesia: a quasi-experimental national study. Addiction. 2020;115(12):2382–92. doi:10.1111/add.15110.
[36] Simansalam S, Brewster JM, Nik Mohamed MH. Training Malaysian Pharmacy Undergraduates with Knowledge and Skills on Smoking Cessation. Am J Pharm Educ. 2015;79(5):71. doi:10.5688/ajpe79571.
[37] El Hajj MS, Sheikh Ali SAS, Awaisu A, Saleh R, Kheir N, Shami R. A pharmacist-delivered smoking cessation program in Qatar: an exploration of pharmacists' and patients' perspectives of the program. Int J Clin Pharm. 2021;43(6):1574–83. doi:10.1007/s11096-021-01286-3.
[38] Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco Product Use Among Adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736–42. doi:10.15585/mmwr.mm6946a4.
[39] Christensen CH, Rostron B, Cosgrove C, Altekruse SF, Hartman AM, Gibson JT, Apelberg B, Inoue-Choi M, Freedman ND. Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population. JAMA Intern Med. 2018;178(4):469–76. doi:10.1001/jamainternmed.2017.8625.
[40] Kim AS, Ko HJ, Kwon JH, Lee JM. Exposure to Secondhand Smoke and Risk of Cancer in Never Smokers: A Meta-Analysis of Epidemiologic Studies. Int J Environ Res Public Health. 2018;15(9):1981. doi:10.3390/ijerph15091981.
[41] Lorensia A, Yudiarso A, Herwansyah FR. 2017. Perception, Effectiveness and Safety of E-Cigarettes (E-Cigarettes) by Active Smokers as Therapy in Smoking Cessation: Mixed Methods with Quantitative and Qualitative Study Approaches. Jurnal of Tropical Pharmacy and Chemistry. 2017;4(2):66–78. doi: https://doi.org/10.25026/jtpc.v4i2.142.
[42] Chean KY, Goh LG, Liew KW, Tan CC, Choi XL, Tan KC, Ooi ST. Barriers to smoking cessation: a qualitative study from the perspective of primary care in Malaysia. BMJ Open. 2019;9(7):e025491. doi:10.1136/bmjopen-2018-025491.
[43] Tregobov N, Poureslami I, Shum J, Aran N, McMillan A, FitzGerald J M. Assessing factors influencing smoking and smoking cessation within Chinese communities in the Greater Vancouver Area: A qualitative exploratory study. Tobacco Prevention & Cessation. 2020;6(57):1–14. doi:10.18332/tpc/126631.
[44] Yan Y, Peng C, Arvin MC, Jin XT, Kim VJ, Ramsey MD, Wang Y, Banala S, Wokosin DL, McLntosh JM, Lavis LD, Drenan RM. Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. Cell Rep. 2018;23(8):2236–44. doi:10.1016/j.celrep.2018.04.062.
[45] Naudé J, Tolu S, Dongelmans M, Torquet N, Valverde S, Rodriguez G, Pons S, Maskos U, Mourot A, Marti F, Faure P. Nicotinic receptors in the ventral tegmental area promote uncertainty-seeking. Nat Neurosci. 2016;19(3):471–8. doi: 10.1038/nn.4223.
[46] Lorensia A, Muntu CM, Suryadinata RV, Septiani R. Effect of lung function disorders and physical activity on smoking and non-smoking students. J Prev Med Hyg. 2021; 62(1):E89–96. doi: 10.15167/2421-4248/jpmh2021.62.1.1763.
[47] Lorensia A, Suryadinata RV, Tirsa L. Identification of Health Knowledge of Lung Function in Predicting Respiratory Disorders in Smokers. Global Medical & Health Communication. 2021;9(2):126–35. https://doi.org/10.29313/gmhc.v9i2.7673.
[48] Giulietti F, Filipponi A, Rosettani G, Giordano P, Lacoacci C, Spannella F, Sarzani R. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice. High Blood Press Cardiovasc Prev. 2020;27(5):349–62. doi:10.1007/s40292-020-00396-9.
[49] Dollerup J, Vestbo J, Murray-Thomas T, Kaplan A, Maartin RJ, . Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study. Clin Epidemiol. 2017;9:231–43. doi:10.2147/CLEP.S127775.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jurnal Sains dan Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
